Efficacy of next treatment received after Nivolumab (Nivo) progression in patients (pts) with non-small-cell lung cancer (NSCLC)

被引：0
|
作者：
Costantini, Adrien
Corny, Jennifer
Fallet, Vincent
Renet, Sophie
Friard, Sylvie
Chouaid, Christos
Duchemann, Boris
Giroux-Leprieur, Etienne
Taillade, Laurent
Doucet, Ludovic
Wislez, Marie
Tredaniel, Jean
Cadranel, Jacques
Jouveshomme, Stephane
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷
关键词：
D O I：
10.1183/1393003.congress-2017.OA1476
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA1476
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Hyper-progressive disease in patients with advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo)
    Costantini, Adrien
    Corny, Jennifer
    Fallet, Vincent
    Renet, Sophie
    Friard, Sylvie
    Chouaid, Christos
    Duchemann, Boris
    Giroux-Leprieur, Etienne
    Taillade, Laurent
    Doucet, Ludovic
    Nguenang, Marina
    Jouveshomme, Stephane
    Wislez, Marie
    Tredaniel, Jean
    Cadranel, Jacques
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [22] Trastuzumab and paclitaxel in patients (pts) with EGFR mutated non-small-cell lung cancer (NSCLC) that express HER2 after progression on EGFR TKI treatment.
    De Langen, Joop
    Kuiper, Justine Leonie
    Thunnissen, Erik
    Hashemi, Sayed M. S.
    Monkhorst, Kim
    Smit, Egbert F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer
    Hasegawa, Takahiro
    Uno, Hajime
    Wei, Lee-Jen
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (05): : 492 - 492
  • [24] An ongoing phase IIIb/IV safety trial of nivolumab (NIVO) in patients (pts) with advanced or metastatic non-small-cell lung cancer (NSCLC) who progressed after receiving 1 or more prior systemic regimens.
    Bauer, Todd Michael
    McCleod, Michael
    Chandler, Jason Claud
    Blumenschein, George R.
    Schwartzberg, Lee Steven
    Burris, Howard
    Waterhouse, David
    Jotte, Robert M.
    Hussein, Maen
    Spigel, David R.
    Thompson, Dana Shelton
    Li, Xuemei
    Reynolds, Craig H.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] RACOTUMOMAB ADMINISTRATION IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) IN PROGRESSION AFTER FIRST LINE THERAPY
    Macias, Amparo
    Alfonso, Sailly
    Santiesteban, Eduardo
    Neninger, E.
    Acosta, Z.
    Gomez, Re
    Ardigo, Laura
    Vazquez, Am
    Crombet, Tania
    Perez, Rolando
    Lage, Agustin
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S121 - S121
  • [26] Angiogenesis inhibitors in the treatment of non-small-cell lung cancer (NSCLC)
    Carcereny Costa, Enric
    Vinolas Segarra, Nuria
    Gascon Vilaplana, Pere
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (04): : 198 - 203
  • [27] Angiogenesis inhibitors in the treatment of non-small-cell lung cancer (NSCLC)
    Enric Carcereny Costa
    Núria Viñolas Segarra
    Pere Gascón Vilaplana
    Clinical and Translational Oncology, 2008, 10
  • [28] NIVOLUMAB IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC): SURVIVAL AND CLINICAL ACTIVITY BY SUBGROUP ANALYSIS
    Brahmer, Julie R.
    Horn, Leora
    Gandhi, Leena
    Spigel, David R.
    Antonia, Scott J.
    Rizvi, Naiyer A.
    Powderly, John D.
    Heist, Rebecca S.
    Carvajal, Richard D.
    Jackman, David M.
    Sequist, Lecia V.
    Smith, David C.
    Leming, Philip D.
    Topalian, Suzanne L.
    Hodi, Stephen
    Snzol, Mario
    Harbison, Christopher T.
    Kollia, Gerogia D.
    Gupta, Ashok
    Gettinger, Scott N.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 157 - 157
  • [29] Effect of Systemic Corticosteroid Therapy on the Efficacy and Safety of Nivolumab in the Treatment of Non-Small-Cell Lung Cancer
    Umehara, Kengo
    Yama, Kaori
    Goto, Keisuke
    Wakamoto, Azusa
    Hatsuyama, Tae
    Honjo, Osamu
    Saikai, Toyohiro
    Fujita, Akihisa
    Sato, Hideki
    CANCER CONTROL, 2021, 28
  • [30] Prolactin as a potential negative predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO)
    Caponnetto, S.
    Mancini, M.
    Manai, C.
    Magri, V.
    Iannantuono, G. M.
    Pellegrino, D.
    Mosillo, C.
    Piesco, G.
    Pomati, G.
    Scagnoli, S.
    Urbano, F.
    Verkhovskaya, S.
    Barchiesi, G.
    Zancla, S.
    Cortesi, E.
    ANNALS OF ONCOLOGY, 2016, 27
12345